Abstract
Coronary atherosclerosis is the pathophysiologic background of coronary artery disease. Vascular calcification is an actively regulated form of calcified tissue metabolism and a common feature of coronary atherosclerotic plaques. Interestingly, systematic research has revealed that vascular mineralization, is also a strong and independent predictor of cardiovascular morbidity and mortality. Recently, several biomarkers, including osteopontin, fetuin-A, matrix-carboxyglutamic acid protein, pyrophosphates, bone morphogenetic proteins, leptin, osteoprotegerin have emerged as surrogate markers of coronary calcification. Furthermore, biomarkers of vascular calcification can be used as prognostic markers of coronary artery disease and can predict future cardiovascular events and mortality. Nevertheless, there is little knowledge on the usefulness of these biomarkers in evaluating the results of treatments targeting coronary artery disease. Within this context, the present review sets out to discuss the role of new biomarkers assessing calcium deposition in coronary arteries and their role in the prognosis, progression, and treatment of cardiovascular disease.
Keywords: Arterial function, Arterial stiffness, Atherosclerosis, Biomarkers, Bone metabolism, Calcium deposition, Calcium metabolism, Coronary artery disease, Coronary calcification, Inflammation, Vascular Calcification, Vulnerable plaque
Current Medicinal Chemistry
Title: Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
Volume: 19 Issue: 6
Author(s): D. Tousoulis, G. Siasos, K. Maniatis, E. Oikonomou, K. Vlasis, A. G. Papavassiliou and C. Stefanadis
Affiliation:
Keywords: Arterial function, Arterial stiffness, Atherosclerosis, Biomarkers, Bone metabolism, Calcium deposition, Calcium metabolism, Coronary artery disease, Coronary calcification, Inflammation, Vascular Calcification, Vulnerable plaque
Abstract: Coronary atherosclerosis is the pathophysiologic background of coronary artery disease. Vascular calcification is an actively regulated form of calcified tissue metabolism and a common feature of coronary atherosclerotic plaques. Interestingly, systematic research has revealed that vascular mineralization, is also a strong and independent predictor of cardiovascular morbidity and mortality. Recently, several biomarkers, including osteopontin, fetuin-A, matrix-carboxyglutamic acid protein, pyrophosphates, bone morphogenetic proteins, leptin, osteoprotegerin have emerged as surrogate markers of coronary calcification. Furthermore, biomarkers of vascular calcification can be used as prognostic markers of coronary artery disease and can predict future cardiovascular events and mortality. Nevertheless, there is little knowledge on the usefulness of these biomarkers in evaluating the results of treatments targeting coronary artery disease. Within this context, the present review sets out to discuss the role of new biomarkers assessing calcium deposition in coronary arteries and their role in the prognosis, progression, and treatment of cardiovascular disease.
Export Options
About this article
Cite this article as:
Tousoulis D., Siasos G., Maniatis K., Oikonomou E., Vlasis K., G. Papavassiliou A. and Stefanadis C., Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease, Current Medicinal Chemistry 2012; 19 (6) . https://dx.doi.org/10.2174/092986712799034833
DOI https://dx.doi.org/10.2174/092986712799034833 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pleiotropic Effects of ARB in Vascular Metabolism - Focusing on Atherosclerosis-Based Cardiovascular Disease
Current Vascular Pharmacology MicroRNAs in Aortic Disease
Current Topics in Medicinal Chemistry Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine Molecular Genetics of Abdominal Aortic Aneurysm: Therapeutic Implications
Current Pharmacogenomics and Personalized Medicine Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Current Vascular Pharmacology miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery
MicroRNA Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics
Current Cardiology Reviews Sleep in Pediatric Pulmonary Diseases
Current Respiratory Medicine Reviews Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Current Genomics Somatic Genome Variations in Health and Disease
Current Genomics Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging MicroRNAs as Biomarkers for Birth Defects
MicroRNA Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Coronary Artery Ectasia-A Review of Current Literature
Current Cardiology Reviews Screening Aortic Drug Treatments Through Arterial Compliance Measurements
Current Vascular Pharmacology Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine Volume Measurement in the Diagnosis of Mounier Kuhn Syndrome and an Unknown Accompanying Pathology: Pulmonary Artery Enlargement
Current Medical Imaging